SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006896
Filing Date
2018-05-15
Accepted
2018-05-15 07:30:44
Documents
5
Period of Report
2017-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35600
2 ex10-1.htm EX-10.1 112341
3 ex10-2.htm EX-10.2 141798
4 ex99-1.htm EX-99.1 18174
5 ex99-1_001.jpg GRAPHIC 35598
  Complete submission text file 0001493152-18-006896.txt   358443
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 18833079
SIC: 2834 Pharmaceutical Preparations